Testing BrioVAD heart pump for severe heart failure
Part of Heart & circulation clinical trials.
This trial tests a new left-ventricular assist device (LVAD) called BrioVAD for people with advanced heart failure who are not getting enough benefit from medicines. If you qualify, the device is implanted to help your heart pump blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- Your heart failure is severe (NYHA Class IV or III with shortness of breath on mild activity).
- Your heart's pumping ability (ejection fraction) is 25% or less (or under 30% if you are on medications or a temporary heart pump).
- You are dependent on IV heart-failure medications or have very low blood flow from your heart.
- You don't have other serious health issues that would make surgery too risky.
- You are not already on a long-term mechanical heart pump.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new total artificial heart called BiVACOR for people with severe heart failure that cannot be helped by standard pumps. It is designed to keep you alive while you wait for a heart transplant.
This trial tests if a combination of a tiny lung-artery pressure sensor (CardioMEMS) and a mechanical heart pump (HeartMate 3) is safe and effective for people with advanced heart failure. If you qualify, you'll either get the heart pump plus standard medical therapy, or continue with standard therapy alone and have your pressure monitored remotely.
This study looks at how well continuous-flow heart pumps (VADs) work in people with advanced heart failure. It aims to improve care and outcomes for adults receiving these devices.
This trial tests a new heart pump (BrioVAD) for people with very advanced heart failure. It aims to help those who are not getting better with standard treatments or who need extra support like IV medicines or a balloon pump.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.